在接受全身异二烯治疗的患者身上,指甲的变化
Dilek Yigit1, Nermin Karaosmanoglu2
1Dermatology and Venereology, Bağcılar Training and Research Hospital, Gençosman Mh. Mustafa Yaşar Cd. No: 5-7 , Güngören/İstanbul, Turkey. dilekyigit1993@gmail.com.
Scientific reports
|October 27, 2024
概括
对的全身性异二烯治疗显著增加了指甲变化的风险,主要是指甲. 这些因异氨酸诱导的指甲发现是可逆的,并且与累积剂量有关,而不是治疗持续时间.
科学领域:
- 皮肤病学 皮肤病学
- 临床研究 临床研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 一般性是一种常见的皮肤疾病.
- 伊索特里诺因是一种全身治疗的药物.
- 爪子的变化是异氨酸治疗的潜在副作用.
研究的目的:
- 为了记录异氨酸诱导的指甲变化.
- 评估异丁氨酸对患者治疗遵守性的影响.
- 为了比较接受异氨酸治疗的患者和局部治疗的患者的指甲变化.
主要方法:
- 一项涉及200名病患者的比较研究.
- 100名患者接受了全身性异丁氨酸;100名患者接受了局部性治疗.
- 记录了指甲的变化,治疗时间和剂量;持续变化的患者被跟踪了6个月.
主要成果:
- 34%的异二胺患者经历了指甲变化,而局部组的指甲变化为11% (p<0.001).
- 常见的指甲变化包括阴,白内障和阴.
- 爪子的变化与总累积异二胺剂量有关,而不是治疗持续时间.
结论:
- 系统性异二烯治疗显著增加了指甲变化的风险,其中桃病是最常见的.
- 异二胺诱导的指甲发现是完全可逆的.
- 这些副作用的发生可能会影响治疗的遵守.
相关概念视频
Changes in Skin Color: Clinical Perspectives
1.7K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.7K
Endocarditis II: Clinical features and Diagnostic Tests
2
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
558
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
558
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117


